Fonar Return on Investment 2010-2023 | FONR
Fonar ROI - Return on Investment Historical Data | |||
---|---|---|---|
Date | TTM Net Income | LT Investments & Debt | Return on Investment |
2023-12-31 | $0.02B | $0.16B | 11.71% |
2023-09-30 | $0.02B | $0.16B | 11.20% |
2023-06-30 | $0.01B | $0.15B | 9.33% |
2023-03-31 | $0.02B | $0.15B | 10.76% |
2022-12-31 | $0.02B | $0.15B | 12.22% |
2022-09-30 | $0.02B | $0.15B | 13.70% |
2022-06-30 | $0.02B | $0.15B | 15.25% |
2022-03-31 | $0.02B | $0.15B | 15.52% |
2021-12-31 | $0.02B | $0.14B | 14.31% |
2021-09-30 | $0.02B | $0.14B | 13.84% |
2021-06-30 | $0.02B | $0.14B | 12.66% |
2021-03-31 | $0.01B | $0.14B | 10.61% |
2020-12-31 | $0.01B | $0.13B | 10.06% |
2020-09-30 | $0.01B | $0.13B | 10.24% |
2020-06-30 | $0.01B | $0.13B | 11.16% |
2020-03-31 | $0.02B | $0.13B | 13.82% |
2019-12-31 | $0.02B | $0.13B | 17.50% |
2019-09-30 | $0.02B | $0.12B | 18.92% |
2019-06-30 | $0.02B | $0.12B | 20.49% |
2019-03-31 | $0.02B | $0.11B | 22.12% |
2018-12-31 | $0.02B | $0.11B | 20.34% |
2018-09-30 | $0.02B | $0.11B | 21.37% |
2018-06-30 | $0.02B | $0.10B | 21.51% |
2018-03-31 | $0.02B | $0.09B | 21.59% |
2017-12-31 | $0.02B | $0.09B | 25.07% |
2017-09-30 | $0.02B | $0.09B | 25.48% |
2017-06-30 | $0.02B | $0.08B | 27.21% |
2017-03-31 | $0.02B | $0.08B | 26.28% |
2016-12-31 | $0.02B | $0.07B | 24.62% |
2016-09-30 | $0.02B | $0.07B | 23.90% |
2016-06-30 | $0.01B | $0.06B | 23.05% |
2016-03-31 | $0.02B | $0.06B | 25.42% |
2015-12-31 | $0.01B | $0.06B | 24.67% |
2015-09-30 | $0.01B | $0.06B | 25.00% |
2015-06-30 | $0.01B | $0.06B | 23.42% |
2015-03-31 | $0.01B | $0.05B | 23.64% |
2014-12-31 | $0.01B | $0.06B | 21.82% |
2014-09-30 | $0.01B | $0.06B | 20.37% |
2014-06-30 | $0.01B | $0.05B | 22.64% |
2014-03-31 | $0.01B | $0.05B | 21.05% |
2013-12-31 | $0.01B | $0.05B | 21.57% |
2013-09-30 | $0.01B | $0.05B | 24.10% |
2013-06-30 | $0.01B | $0.05B | 25.20% |
2013-03-31 | $0.01B | $0.05B | 36.36% |
2012-12-31 | $0.01B | $0.02B | 61.54% |
2012-09-30 | $0.01B | $0.01B | 66.67% |
2012-06-30 | $0.01B | $0.01B | 72.73% |
2012-03-31 | $0.01B | $0.01B | 70.00% |
2011-12-31 | $0.01B | $0.01B | 82.76% |
2011-09-30 | $0.01B | $0.01B | 125.00% |
2011-06-30 | $0.00B | $0.01B | 400.00% |
2011-03-31 | $0.00B | $0.00B | -88.89% |
2010-12-31 | $0.00B | $-0.00B | -28.57% |
2010-09-30 | $-0.00B | $-0.00B | 23.53% |
2010-06-30 | $-0.00B | $-0.00B | 47.06% |
2010-03-31 | $-0.00B | $-0.00B | 53.33% |
2009-12-31 | $-0.00B | $-0.01B | 30.77% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.106B | $0.099B |
FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $189.499B | 24.60 |
Stryker (SYK) | United States | $128.469B | 31.85 |
Medtronic (MDT) | Ireland | $105.230B | 14.90 |
Boston Scientific (BSX) | United States | $99.939B | 33.23 |
EssilorLuxottica (ESLOY) | France | $98.203B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $42.924B | 0.00 |
Haleon (HLN) | United Kingdom | $36.986B | 28.93 |
ResMed (RMD) | United States | $27.191B | 27.18 |
Terumo (TRUMY) | Japan | $25.327B | 35.77 |
Zimmer Biomet Holdings (ZBH) | United States | $25.081B | 16.15 |
Baxter (BAX) | United States | $20.095B | 14.66 |
Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
Insulet (PODD) | United States | $12.094B | 63.50 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.404B | 0.00 |
Demant (WILYY) | Denmark | $10.151B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.349B | 24.87 |
BellRing Brands (BRBR) | United States | $7.231B | 38.88 |
Haemonetics (HAE) | United States | $4.275B | 21.86 |
Lantheus Holdings (LNTH) | United States | $4.232B | 10.93 |
Perrigo (PRGO) | Ireland | $4.060B | 11.61 |
GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
Envista Holdings (NVST) | United States | $3.399B | 12.93 |
Prestige Consumer Healthcare (PBH) | United States | $3.379B | 15.98 |
QuidelOrtho (QDEL) | United States | $2.695B | 9.78 |
Neogen (NEOG) | United States | $2.634B | 25.33 |
Green Thumb Industries (GTBIF) | United States | $2.613B | 82.80 |
ICU Medical (ICUI) | United States | $2.347B | 17.51 |
TG Therapeutics (TGTX) | United States | $2.162B | 700.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.046B | 0.00 |
Owens & Minor (OMI) | United States | $1.903B | 18.27 |
Verano Holdings (VRNOF) | United States | $1.686B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.618B | 0.00 |
InMode (INMD) | Israel | $1.480B | 7.66 |
National Vision Holdings (EYE) | United States | $1.479B | 46.05 |
LeMaitre Vascular (LMAT) | United States | $1.430B | 47.50 |
AdaptHealth (AHCO) | United States | $1.277B | 9.61 |
Warby Parker (WRBY) | United States | $1.241B | 0.00 |
AtriCure (ATRC) | United States | $1.117B | 0.00 |
MacroGenics (MGNX) | United States | $1.044B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.725B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.709B | 0.00 |
Evolus (EOLS) | United States | $0.698B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.698B | 15.07 |
Jin Medical (ZJYL) | China | $0.673B | 0.00 |
Canopy Growth (CGC) | Canada | $0.610B | 0.00 |
Quanterix (QTRX) | United States | $0.610B | 0.00 |
Valneva SE (VALN) | France | $0.556B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.526B | 11.40 |
TerrAscend (TSNDF) | Canada | $0.510B | 0.00 |
PetIQ (PETQ) | United States | $0.477B | 17.80 |
ZimVie (ZIMV) | United States | $0.427B | 26.15 |
Biote (BTMD) | United States | $0.426B | 4.05 |
OraSure Technologies (OSUR) | United States | $0.399B | 6.61 |
Zynex (ZYXI) | United States | $0.391B | 45.00 |
Surmodics (SRDX) | United States | $0.379B | 40.92 |
Aurora Cannabis (ACB) | Canada | $0.322B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.320B | 31.77 |
Cerus (CERS) | United States | $0.305B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.253B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.244B | 14.91 |
Omeros (OMER) | United States | $0.199B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.195B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.194B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.187B | 0.00 |
Veru (VERU) | United States | $0.184B | 0.00 |
High Tide (HITI) | Canada | $0.177B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
FitLife Brands (FTLF) | United States | $0.132B | 21.19 |
Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.125B | 62.70 |
Allurion Technologies (ALUR) | United States | $0.113B | 0.00 |
InterCure (INCR) | Israel | $0.108B | 18.23 |
Cellectar Biosciences (CLRB) | United States | $0.107B | 0.00 |
Safety Shot (SHOT) | United States | $0.102B | 0.00 |
MariMed (MRMD) | United States | $0.102B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
Brainsway (BWAY) | Israel | $0.085B | 0.00 |
Chimerix (CMRX) | United States | $0.082B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.072B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.061B | 3.97 |
Apyx Medical (APYX) | United States | $0.048B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.041B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 13.91 |
Modular Medical (MODD) | United States | $0.034B | 0.00 |
Exagen (XGN) | United States | $0.025B | 0.00 |
Nephros (NEPH) | United States | $0.021B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.020B | 0.00 |
Flora Growth (FLGC) | United States | $0.019B | 0.00 |
Agape ATP (ATPC) | $0.018B | 0.00 | |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GlucoTrack (GCTK) | United States | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 71.36 |
ProSomnus (OSA) | United States | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |